<DOC>
	<DOCNO>NCT02353273</DOCNO>
	<brief_summary>The objective study evaluate systemic exposure WH-1 ointment include Salvigenin Asiaticoside A subject chronic diabetic foot ulcer follow topical application WH-1 .</brief_summary>
	<brief_title>The Pharmacokinetic Study WH-1 Ointment Subjects With Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description>This trial design open label , non-comparative study evaluate pharmacokinetic profile salvigenin asiaticoside A subject receive treatment WH-1 ointment diabetic foot ulcer . A total 12 subject complete study . Each subject apply one dose WH-1 ointment Day 1 follow blood sample collection , twice day WH-1 application Day 2 Day 13 , another blood sample collection schedule Day 14 one dose application .</detailed_description>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Male female least 20 year age ; 2 . Diabetes mellitus ( type I II ) diagnose HbA1c ≤ 12.0 % measure screening within three month prior randomization ; 3 . The target diabetic foot ulcer must follow characteristic : 1 . ≤ Grade 2 per Wagner Ulcer Classification System ; 2 . Lower limb ; 3 . Noinfected ; 4 . A crosssectional area 1 25 cm2 postdebridement ; 4 . If female childbearing potential negative pregnancy test neither breastfeeding intending become pregnant study ; 5 . Able willing follow study schedule visit , comply study procedure , sign inform consent . 1 . Acute Charcot ' neuroarthropathy determine clinical and/or radiographic examination ; 2 . Poor nutritional status define albumin &lt; 2.5 g/dL ; 3 . AST and/or ALT &gt; 3X normal upper limit ; 4 . Clearance Creatinine ( Ccr ) &lt; 30 ml/min ; 5 . Treatment immunosuppressive chemotherapeutic agent , radiotherapy systemic corticosteroid le 4 week prior enroll ; 6 . A psychiatric condition ( e.g. , suicidal ideation ) , current chronic alcohol drug abuse problem , determine subject ' medical history , , opinion Investigator , may pose threat subject compliance 7 . Subjects receive experimental agent within 30 day , prior enroll . 8 . Subjects receive WH1 ointment within 30 day , prior enroll . 9 . Subjects history smoking ( define 20 cigarette per day ) within 3 month prior admission Hospital site . 10 . Judged investigator suitable study reason .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>WH-1 , Diabetic Foot , Ulcer</keyword>
</DOC>